In Brief: Twin Labs Ocuguard
This article was originally published in The Tan Sheet
Executive Summary
Twin Labs Ocuguard: The OTC multivitimin/mineral/antioxidant nutrient capsule, taken twice daily, did not improve the vision in patients with advanced age-related macular degeneration (ARMD) but kept it from getting worse, a study group on the disease concludes. Published in the January issue of the Journal of the American Optometric Association, the 18-month prospective, double-blind, case-controlled study compares Ocuguard to a placebo. The subjects were 71 U.S. veterans in their 70s with advanced ARMD...